Previous Article | Next Article ![]()
Infection and Immunity, June 2001, p. 3809-3816, Vol. 69, No. 6
Molecular Microbiology Group, Division of
Cell and Molecular Medicine, University of Southampton Medical School,
Southampton General Hospital, Southampton SO16 6YD, United Kingdom
Received 2 November 2000/Returned for modification 8 January
2001/Accepted 14 March 2001
The opc gene from Neisseria meningitidis
was cloned into the pRSETA vector, and recombinant protein was
expressed at high levels in Escherichia coli. The protein
was readily purified by affinity chromatography and used for
immunization with conventional Al(OH)3 adjuvant or after
incorporation into liposomes and Zwittergent micelles. The resulting
sera were analyzed for their ability to recognize purified recombinant
protein and "native" protein in an enzyme immunoassay with outer
membranes and by whole-cell immunofluorescence. Immunization with
Al(OH)3 induced high levels of antibodies which reacted
with the purified protein but did not recognize whole cells. In
contrast, liposomes and micelles induced antibodies which reacted with
the native protein in whole cells. The addition of monophosphoryl lipid
A (MPLA) to either liposomes or micelle preparations increased the
magnitude of the immune response and induced a wider range of
immunoglobulin subclasses. This was associated with the ability of the
sera to induce complement-mediated killing of the homologous strain.
The most effective bactericidal activity was observed with Opc protein
incorporated into liposomes containing MPLA. The magnitude of the
bactericidal effect was strongly influenced by the level of expression
of the Opc protein and was abolished by limited variation in the
sequence of the protein expressed by heterologous strains.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.6.3809-3816.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Immunization with Recombinant Opc Outer Membrane
Protein from Neisseria meningitidis: Influence of Sequence
Variation and Levels of Expression on the Bactericidal Immune
Response against Meningococci


*
Corresponding author. Mailing address: Molecular
Microbiology Group, Division of Cell and Molecular Medicine, Mailpoint
814, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, United Kingdom. Phone: 44-023-80796974. Fax: 44-023-80796992. E-mail:
jeh{at}soton.ac.uk.
Present address: Wellcome Trust Centre for the Epidemiology of
Infectious Disease, Department of Zoology, University of Oxford, Oxford
OX1 3PS, United Kingdom.
Present address: Department of Paediatrics, University of Oxford,
John Radcliffe Hospital, Headington, Oxford OX3 9DU, United Kingdom.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|